Residency curricula on physician-pharmaceutical industry interaction: A CERA study

David V. Evans, Richard C. Waters, Cara Olsen, Mark Stephens, Steven R. Brown

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BACKGROUND AND OBJECTIVES: Physician interaction with pharmaceutical representatives results in less evidence-based prescribing and increased costs. Many organizations have called for strong conflict of interest policies in academic institutions. Implementing policy without educational interventions may not adequately address the influence of industry on physician prescribing patterns. The objective of this study is to assess the implementation and content of family medicine residency curricula on the physician-pharmaceutical industry relationship. METHODS: We surveyed US family medicine program directors using the Council of Academic Family Medicine Educational Research Alliance (CERA) platform. The presence of a formal curriculum on the physician-industry interaction and specific curricular elements (ethics of interaction, understanding detailing sessions and advertisements, use of unbiased pharmaceutical information) were the outcome measures of interest. RESULTS: Fifty-two percent (212 of 406) of program directors responded. Forty percent (95% confidence interval [CI]: 33%-46%) reported having a formal curriculum on physician-pharmaceutical industry interactions. The presence of a formal curriculum was more likely in residencies permitting interaction with industry (52% [48/92] versus 30% [36/120]) or with a university affiliation (43% [75/173] versus 19% [7/36]). The use of unbiased sources of information relating to pharmaceutical products and the ethics of the physician-pharmaceutical industry relationship were the most common curricular elements (59% and 55%, respectively). CONCLUSIONS: This study shows that less than half of US family medicine programs have a curriculum addressing physician-industry interactions. Further research on the efficacy of and barriers to curriculum creation and implementation is warranted.

Original languageEnglish (US)
Pages (from-to)44-48
Number of pages5
JournalFamily medicine
Volume48
Issue number1
StatePublished - Jan 1 2016

Fingerprint

Drug Industry
Internship and Residency
Curriculum
Physicians
Industry
Medicine
Pharmacy Ethics
Physicians' Practice Patterns
Pharmaceutical Preparations
Conflict of Interest
Research
Ethics
Outcome Assessment (Health Care)
Organizations
Confidence Intervals
Costs and Cost Analysis

All Science Journal Classification (ASJC) codes

  • Family Practice

Cite this

Evans, D. V., Waters, R. C., Olsen, C., Stephens, M., & Brown, S. R. (2016). Residency curricula on physician-pharmaceutical industry interaction: A CERA study. Family medicine, 48(1), 44-48.
Evans, David V. ; Waters, Richard C. ; Olsen, Cara ; Stephens, Mark ; Brown, Steven R. / Residency curricula on physician-pharmaceutical industry interaction : A CERA study. In: Family medicine. 2016 ; Vol. 48, No. 1. pp. 44-48.
@article{207a83a8031242fe9b69b1c93fb2b2b4,
title = "Residency curricula on physician-pharmaceutical industry interaction: A CERA study",
abstract = "BACKGROUND AND OBJECTIVES: Physician interaction with pharmaceutical representatives results in less evidence-based prescribing and increased costs. Many organizations have called for strong conflict of interest policies in academic institutions. Implementing policy without educational interventions may not adequately address the influence of industry on physician prescribing patterns. The objective of this study is to assess the implementation and content of family medicine residency curricula on the physician-pharmaceutical industry relationship. METHODS: We surveyed US family medicine program directors using the Council of Academic Family Medicine Educational Research Alliance (CERA) platform. The presence of a formal curriculum on the physician-industry interaction and specific curricular elements (ethics of interaction, understanding detailing sessions and advertisements, use of unbiased pharmaceutical information) were the outcome measures of interest. RESULTS: Fifty-two percent (212 of 406) of program directors responded. Forty percent (95{\%} confidence interval [CI]: 33{\%}-46{\%}) reported having a formal curriculum on physician-pharmaceutical industry interactions. The presence of a formal curriculum was more likely in residencies permitting interaction with industry (52{\%} [48/92] versus 30{\%} [36/120]) or with a university affiliation (43{\%} [75/173] versus 19{\%} [7/36]). The use of unbiased sources of information relating to pharmaceutical products and the ethics of the physician-pharmaceutical industry relationship were the most common curricular elements (59{\%} and 55{\%}, respectively). CONCLUSIONS: This study shows that less than half of US family medicine programs have a curriculum addressing physician-industry interactions. Further research on the efficacy of and barriers to curriculum creation and implementation is warranted.",
author = "Evans, {David V.} and Waters, {Richard C.} and Cara Olsen and Mark Stephens and Brown, {Steven R.}",
year = "2016",
month = "1",
day = "1",
language = "English (US)",
volume = "48",
pages = "44--48",
journal = "Family Medicine",
issn = "0742-3225",
publisher = "Society of Teachers of Family Medicine",
number = "1",

}

Evans, DV, Waters, RC, Olsen, C, Stephens, M & Brown, SR 2016, 'Residency curricula on physician-pharmaceutical industry interaction: A CERA study', Family medicine, vol. 48, no. 1, pp. 44-48.

Residency curricula on physician-pharmaceutical industry interaction : A CERA study. / Evans, David V.; Waters, Richard C.; Olsen, Cara; Stephens, Mark; Brown, Steven R.

In: Family medicine, Vol. 48, No. 1, 01.01.2016, p. 44-48.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Residency curricula on physician-pharmaceutical industry interaction

T2 - A CERA study

AU - Evans, David V.

AU - Waters, Richard C.

AU - Olsen, Cara

AU - Stephens, Mark

AU - Brown, Steven R.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - BACKGROUND AND OBJECTIVES: Physician interaction with pharmaceutical representatives results in less evidence-based prescribing and increased costs. Many organizations have called for strong conflict of interest policies in academic institutions. Implementing policy without educational interventions may not adequately address the influence of industry on physician prescribing patterns. The objective of this study is to assess the implementation and content of family medicine residency curricula on the physician-pharmaceutical industry relationship. METHODS: We surveyed US family medicine program directors using the Council of Academic Family Medicine Educational Research Alliance (CERA) platform. The presence of a formal curriculum on the physician-industry interaction and specific curricular elements (ethics of interaction, understanding detailing sessions and advertisements, use of unbiased pharmaceutical information) were the outcome measures of interest. RESULTS: Fifty-two percent (212 of 406) of program directors responded. Forty percent (95% confidence interval [CI]: 33%-46%) reported having a formal curriculum on physician-pharmaceutical industry interactions. The presence of a formal curriculum was more likely in residencies permitting interaction with industry (52% [48/92] versus 30% [36/120]) or with a university affiliation (43% [75/173] versus 19% [7/36]). The use of unbiased sources of information relating to pharmaceutical products and the ethics of the physician-pharmaceutical industry relationship were the most common curricular elements (59% and 55%, respectively). CONCLUSIONS: This study shows that less than half of US family medicine programs have a curriculum addressing physician-industry interactions. Further research on the efficacy of and barriers to curriculum creation and implementation is warranted.

AB - BACKGROUND AND OBJECTIVES: Physician interaction with pharmaceutical representatives results in less evidence-based prescribing and increased costs. Many organizations have called for strong conflict of interest policies in academic institutions. Implementing policy without educational interventions may not adequately address the influence of industry on physician prescribing patterns. The objective of this study is to assess the implementation and content of family medicine residency curricula on the physician-pharmaceutical industry relationship. METHODS: We surveyed US family medicine program directors using the Council of Academic Family Medicine Educational Research Alliance (CERA) platform. The presence of a formal curriculum on the physician-industry interaction and specific curricular elements (ethics of interaction, understanding detailing sessions and advertisements, use of unbiased pharmaceutical information) were the outcome measures of interest. RESULTS: Fifty-two percent (212 of 406) of program directors responded. Forty percent (95% confidence interval [CI]: 33%-46%) reported having a formal curriculum on physician-pharmaceutical industry interactions. The presence of a formal curriculum was more likely in residencies permitting interaction with industry (52% [48/92] versus 30% [36/120]) or with a university affiliation (43% [75/173] versus 19% [7/36]). The use of unbiased sources of information relating to pharmaceutical products and the ethics of the physician-pharmaceutical industry relationship were the most common curricular elements (59% and 55%, respectively). CONCLUSIONS: This study shows that less than half of US family medicine programs have a curriculum addressing physician-industry interactions. Further research on the efficacy of and barriers to curriculum creation and implementation is warranted.

UR - http://www.scopus.com/inward/record.url?scp=84954530942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954530942&partnerID=8YFLogxK

M3 - Article

C2 - 26950665

AN - SCOPUS:84954530942

VL - 48

SP - 44

EP - 48

JO - Family Medicine

JF - Family Medicine

SN - 0742-3225

IS - 1

ER -